| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 184,332 | 197,326 | 169,855 | 191,569 | | Cost of Revenue | 104,402 | 111,859 | 102,562 | 111,999 | | | Gross Profit | 79,930 | 85,467 | 67,293 | 79,570 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 24,541 | 20,587 | 21,722 | 20,085 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 55,389 | 64,880 | 45,571 | 59,485 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,220 | 1,016 | (1,390) | 1,835 | | Earnings Before Interest And Taxes | 56,609 | 65,896 | 44,181 | 61,320 | | Interest Expense | 274 |
-
|
-
|
-
| | Income Before Tax | 56,335 | 65,896 | 44,181 | 61,320 | | Income Tax Expense | 21,708 | 25,384 | 17,028 | 24,066 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 34,627 | 40,512 | 27,153 | 37,254 | | | Non-recurring Events | | Discontinued Operations |
-
| 1,557 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 34,627 | 42,069 | 27,153 | 37,254 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $34,627 | $42,069 | $27,153 | $37,254 |
|
1.34% Nasdaq 
Income Statement
